Pure Global

HemosIL ReadiPlasTin - Taiwan Registration 27747d3c75f6eca33624180d36178363

Access comprehensive regulatory information for HemosIL ReadiPlasTin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 27747d3c75f6eca33624180d36178363 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
27747d3c75f6eca33624180d36178363
Registration Details
Taiwan FDA Registration: 27747d3c75f6eca33624180d36178363
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

HemosIL ReadiPlasTin
TW: ๅธŒๆ‘ฉ่ฅฟ็ˆพๅ‡่ก€้…ถๅŽŸๆ™‚้–“-็บ–็ถญ่›‹็™ฝๅŽŸ่ฉฆๅŠ‘
Risk Class 2
MD

Registration Details

27747d3c75f6eca33624180d36178363

Ministry of Health Medical Device Import No. 031739

DHA05603173905

Company Information

United States

Product Details

This product is an in vitro diagnostic thrombin kinase reagent manufactured using recombinant human tissue factors for the quantitative analysis of prothrombin time (PT) and fibrinogen in citrate-treated human plasma. This product is required for use with ACL TOP series analyzers.

B Hematology and pathology devices

B7340 Fibrinogen Confirmation System

Imported from abroad

Dates and Status

Oct 18, 2018

Oct 18, 2028